“Because of the Biden-Harris lower cost prescription drug law, the Inflation Reduction Act, which established the Medicare Prescription Drug Inflation Rebate Program, some people with Medicare ...
The Inflation Reduction Act was signed into law on August 16, 2022, and the debate over its Medicare-related benefits and impact on the prescription drug market has been raging ever since.
This access and Medicare’s success are now under threat because of price-setting policies, including the ones contained in the Inflation Reduction Act’s (IRA) new Medicare “negotiation” program.